New in this edition:* Third-generation antipsychotics with major additions and changes * Pharmacogenomics fully revised * ECT thoroughly revised and updated* BLT / rTMS with extended references* Extrapyramidal side effects chart extended* Antidepressants vilazodone and vortioxetine with extended coverage * New chart of agents under investigation for treatment of substance use disorders* Approved and off-label indications updated* New unapproved treatments with significant updates, including anti-inflammatories, hormones, and 5-HT3 antagonists, in depres-sion, dementia, schizophrenia, and anxiety disorders* New agents include: TGAs N-arylpiperazine (brexiprazole, Rexulti) and phenylpiperazine: (cariprazine, Vrylar), hypnotic suvorexant (Belsomra)* New formulations and trade names include: Brisdelle (paroxetine mesylate), Irenka (duloxetine capsules), Invega Trinza, Dyanavel XR, Evekeo, Zenzedi, Adzenys XR-ODT, Aptensio XR, Quillichew ER / Quil-livant XRThe Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.* Independent, unbiased* Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions...) for a quick overview of treatment options* Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing impli-cations, and much more - all you need to know for each class of drug* Potential interactions and side effects summarized in comparison charts* With instantly recognizable icons and in full color throughout, allow-ing you to find at a glance all the information you seek * Clearly written patient information sheets available for download as printable PDF files This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Ric M. Procyshyn; BSc (Pharm), MSc, PharmD, PhD; Department ofPsychiatry, University of British Columbia, Vancouver, BC, Canada;British Columbia Mental Health & Addictions Research Institute,Vancouver, BC, Canada.Kalyna Z. Bezchlibnyk-Butler; BScPhm, FCSHP; Toronto, ON, Canada.J. Joel Jeffries; MB, FRCPC, DFCPA; Centre for Addiction and MentalHealth and Department of Psychiatry, University of Toronto,Toronto, ON, Canada.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Gratis für den Versand innerhalb von/der Deutschland
Versandziele, Kosten & DauerAnbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Spiralbindung. Zustand: Sehr gut. Gebraucht - Sehr gut SG - leichte Beschädigungen oder Verschmutzungen, ungelesenes Mängelexemplar, gestempelt - The Clinical Handbook of Psychotropic Drugs has become a standardreference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals. - Independent, unbiased - Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions.) for a quick overview of treatment options - Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more - all you need to know for each class of drug - Potential interactions and side effects summarized in comparison charts - With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek - Clearly written patient information sheets available for download as printable PDF files This book is a must for everyone who needs an up-to-date, easy-touse, comprehensive summary of all the most relevant information about psychotropic drugs. New in this edition: - Third-generation antipsychotics with major additions and changes - Pharmacogenomics fully revised - ECT thoroughly revised and updated - BLT / rTMS with extended references - Extrapyramidal side effects chart extended - Antidepressants vilazodone and vortioxetine with extended coverage - New chart of agents under investigation for treatment of substance use disorders - Approved and off-label indications updated - New unapproved treatments with significant updates, including anti-inflammatories, hormones, and 5-HT3 antagonists, in depression, dementia, schizophrenia, and anxiety disorders - New agents include: TGAs N-arylpiperazine (brexiprazole, Rexulti) and phenylpiperazine: (cariprazine, Vrylar), hypnotic suvorexant (Belsomra) - New formulations and tradenames include: Brisdelle (paroxetine mesylate), Irenka (duloxetine capsules), Invega Trinza, Dyanavel XR, Evekeo, Zenzedi, Adzenys XR-ODT, Aptensio XR, Quillichew ER / Quillivant XR. Artikel-Nr. INF1000522081
Anzahl: 3 verfügbar